Works matching IS 02780232 AND DT 2012 AND VI 30 AND IP 2
Results: 9
Polymorphisms of VEGF, GSTM1 and GSTT1 genes in multiple myeloma risk.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 105, doi. 10.1002/hon.1009
- By:
- Publication type:
- Article
Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 82, doi. 10.1002/hon.1001
- By:
- Publication type:
- Article
Langerhans cell histiocytosis with central nervous system involvement-complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 101, doi. 10.1002/hon.1005
- By:
- Publication type:
- Article
Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 98, doi. 10.1002/hon.1004
- By:
- Publication type:
- Article
Extracellular ATP induces CD44 shedding from macrophage-like P388D1 cells via the P2X7 receptor.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 70, doi. 10.1002/hon.1008
- By:
- Publication type:
- Article
Overexpression of apoptosis-associated speck-like protein in P388D1 murine lymphoma cells affects metastatic properties.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 62, doi. 10.1002/hon.1010
- By:
- Publication type:
- Article
Novel agents-based regimens as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 57, doi. 10.1002/hon.1007
- By:
- Publication type:
- Article
Epidermal growth factor receptor expression in acute myelogenous leukaemia is associated with clinical prognosis.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 89, doi. 10.1002/hon.1002
- By:
- Publication type:
- Article
Azacitidine has limited activity in 'real life' patients with MDS and AML: a single centre experience.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 2, p. 76, doi. 10.1002/hon.986
- By:
- Publication type:
- Article